BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38625007)

  • 1. US-guided Percutaneous Radiofrequency Ablation for Secondary Hyperparathyroidism: Long-term Outcomes and Prognostic Factors.
    Yue W; Jiang T; Ai Z; Deng E; Chai H; Li X; He H; Zhang Z; Weng N; Qin X; Fan J; Tang X; Heng W; Li Y; Sun L; Peng C; Xu H
    Radiology; 2024 Apr; 311(1):e231852. PubMed ID: 38625007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation for patients with recurrent or persistent secondary hyperparathyroidism after parathyroidectomy: initial experience.
    Jiang T; Deng E; Chai H; Weng N; He H; Zhang Z; Li D; Yue W; Peng C; Xu HX
    Endocrine; 2024 Mar; 83(3):681-690. PubMed ID: 37725290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. US-guided percutaneous radiofrequency ablation of secondary hyperparathyroidism as a bridge to renal transplantation.
    Yue W; Jiang T; Deng E; Chai H; Weng N; He H; Zhang Z; Xu D; Peng C
    Int J Hyperthermia; 2023; 40(1):2223370. PubMed ID: 37344379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimally Invasive Treatment for Benign Parathyroid Lesions: Treatment Efficacy and Safety Based on Nodule Characteristics.
    Ha EJ; Baek JH; Baek SM
    Korean J Radiol; 2020 Dec; 21(12):1383-1392. PubMed ID: 32767864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Ultrasound-guided Radiofrequency Ablation of Parathyroid Hyperplasia: Single Session vs. Two-Session for Effect on Hypocalcemia.
    Zeng Z; Peng CZ; Liu JB; Li YW; He HF; Hu QH; Lin B; Shen XG
    Sci Rep; 2020 Apr; 10(1):6206. PubMed ID: 32277134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism: a retrospective study.
    Qiu X; Gao M; Zhang D; Ji F
    Sci Rep; 2023 Oct; 13(1):16949. PubMed ID: 37805586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism with or without previous parathyroidectomy: a retrospective study.
    Chen CC; Chen HL; Chiang PL; Luo SD; Chang YH; Chen WC; Wang CK; Lin AN; Chen YS; Chi SY; Lin WC
    Int J Hyperthermia; 2022; 39(1):907-917. PubMed ID: 35848429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of radiofrequency ablation versus parathyroidectomy for secondary hyperparathyroidism in dialysis patients: a single-center retrospective study.
    Ren M; Zheng D; Wu J; Liu Y; Peng C; Shen W; Lin B
    Sci Rep; 2022 Jun; 12(1):10289. PubMed ID: 35717444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microwave ablation versus radiofrequency ablation for patients with primary and secondary hyperparathyroidism: a meta-analysis.
    Xu W; Li S; Cheng F; Gong L; Tang W; Lu J; Li Y; Wang Z
    Int Urol Nephrol; 2023 Sep; 55(9):2237-2247. PubMed ID: 36892812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of contrast-enhanced ultrasonography in radiofrequency ablation of secondary hyperparathyroidism.
    Qin X; Wang B; Li B; Lin C; Liu X; Xie X
    Ren Fail; 2021 Dec; 43(1):445-451. PubMed ID: 33663332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound-guided microwave and radiofrequency ablation for primary hyperparathyroidism: a prospective, multicenter study.
    Liu F; Liu Y; Peng C; Yu M; Wu S; Qian L; Han Z; Yu J; Chai H; Liang P
    Eur Radiol; 2022 Nov; 32(11):7743-7754. PubMed ID: 35593958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound-Guided Radiofrequency Ablation in Tertiary Hyperparathyroidism: A Prospective Study.
    Deng E; Jiang T; Chai H; Weng N; He H; Zhang Z; Peng C; Yue W; Xu H
    Korean J Radiol; 2024 Mar; 25(3):289-300. PubMed ID: 38413113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. US-guided Microwave Ablation of Hyperplastic Parathyroid Glands: Safety and Efficacy in Patients with End-Stage Renal Disease-A Pilot Study.
    Zhuo L; Peng LL; Zhang YM; Xu ZH; Zou GM; Wang X; Li WG; Lu MD; Yu MA
    Radiology; 2017 Feb; 282(2):576-584. PubMed ID: 27552557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of ultrasound-guided radiofrequency ablation of hyperplastic parathyroid gland for secondary hyperparathyroidism associated with chronic kidney disease.
    Peng C; Zhang Z; Liu J; Chen H; Tu X; Hu R; Ni J; Weng N; Pang H; Xue Z
    Head Neck; 2017 Mar; 39(3):564-571. PubMed ID: 28032671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of microwave ablation for ectopic secondary hyperparathyroidism: a feasibility study.
    Li X; Wei Y; Shao H; Peng L; An C; Yu MA
    Int J Hyperthermia; 2019; 36(1):647-653. PubMed ID: 31305184
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and efficiency of microwave ablation for recurrent and persistent secondary hyperparathyroidism after parathyroidectomy: A retrospective pilot study.
    Yu MA; Yao L; Zhang L; Peng L; Zhuo L; Zhang Y; Li W; Lv MD
    Int J Hyperthermia; 2016; 32(2):180-6. PubMed ID: 26606889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications after radiofrequency ablation of hyperparathyroidism secondary to chronic kidney disease.
    Lin LP; Lin M; Wu SS; Liu WH; Zhang L; Ruan YP; Gao MZ; Hong FY
    Ren Fail; 2023 Dec; 45(1):2215334. PubMed ID: 37345712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Ultrasound-Guided Radiofrequency Ablation for Primary Hyperparathyroidism: A Prospective Study.
    Chai HH; Zhao Y; Zeng Z; Ye RZ; Hu QH; He HF; Baek JH; Peng CZ
    Korean J Radiol; 2022 May; 23(5):555-565. PubMed ID: 35506529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of microwave ablation treatments in patients with renal secondary and primary hyperparathyroidism.
    Ma H; Ouyang C; Huang Y; Xing C; Cheng C; Liu W; Yuan D; Zeng M; Yu X; Ren H; Yuan Y; Zhang L; Xu F; Cui Y; Ren W; Huang H; Qian H; Fan B; Wang N
    Ren Fail; 2020 Nov; 42(1):66-76. PubMed ID: 31928297
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiofrequency ablation for primary hyperparathyroidism and risk factors for postablative eucalcemic parathyroid hormone elevation.
    Peng CZ; Chai HH; Zhang ZX; Hu QH; Zeng Z; Cui AL; Pang HS; Ruan LT
    Int J Hyperthermia; 2022; 39(1):490-496. PubMed ID: 35285391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.